•NO, RSNO, ONOO-, NO+, •NOO, NOx - Dynamic regulation of oxidant scavenging, nitric oxide stores, and cyclic GMP-independent cell signaling

Antioxidants and Redox Signaling

Volumn 3, Issue 2, 2001, Pages 249-260

  Heck, Diane E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; NITROSO DERIVATIVE; NUCLEIC ACID; OXIDIZING AGENT; PROTEIN; REDUCING AGENT; SUGAR; NITRATE; PEROXYNITRIC ACID; SCAVENGER;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOMYOPATHY; CELL METABOLISM; CELLULAR DISTRIBUTION; ENZYME RELEASE; HUMAN; MOLECULAR INTERACTION; MULTIFACTORIAL GENETIC DISORDER; MULTIPLE ORGAN FAILURE; MUSCLE CONTRACTION; NERVE DEGENERATION; NEUROTRANSMISSION; NITRATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; ANIMAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC GMP; FREE RADICAL SCAVENGERS; HUMANS; NITRATES; NITRIC OXIDE; SIGNAL TRANSDUCTION;

EID: 0034744082     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601300185205     Document Type: Review

References (139)

1. Altug S, Demiryurek AT, Cakici I, and Kanzik I. The beneficial effects of peroxynitrite on ischaemia-reperfusion arrhythmias in rat isolated hearts. Eur J Pharmacol 384: 157-162, 1999.
2. Andrew PJ, and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531, 1999.
3. Apffel CA. Nonimmunological host defenses: a review. Cancer Res 36: 1527-1537, 1976.
4. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, and Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55: 1078-1087, 1999.
5. Arteel GE, Briviba K, and Sies H. Protection against peroxynitrite. FEBS Lett 445: 226-230, 1999.
6. Aslund F, Zheng M, Beckwith J, and Storz G. Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thiol-disulfide status. Proc Natl Acad Sci U S A 96: 6161-6165, 1999.
7. Badorff C, Fichtischerer B, Rhoads RE, Zeiher AM, Muelsch A, Dimmeler S, and Knowlton KU. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: a protective mechanism against enteroviral cardiomyopathy. Circulation 102: 2276-2281, 2000.
8. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
9. Baker-Malcolm JF, Haeffner-Gormley L, Wang L, Anders MW, and Thorpe C. Elimination reactions in the medium-chain acyl-CoA dehydrogenase: bioactivation of cytotoxic 4-thiaalkanoic acids. Biochemistry 37: 1383-1393, 1998.
10. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844, 1996.
11. Beckman JS, and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
12. Blackburn ML, Ketterer B, Meyer DJ, Juett AM, and Bull AW. Characterization of the enzymatic and nonenzymatic reaction of 13-oxooctadecadienoic acid with glutathione. Chem Res Toxicol 10: 1364-1371, 1997.
13. Boese M, Keese MA, Becker K, Busse R, and Mulsch A. Inhibition of glutathione reductase by dinitrosyl-iron-dithiolate complex. J Biol Chem 272: 21767-21773, 1997.
14. Bolton TB, Prestwich SA, Zholos AV, and Gordienko DV. Excitation-contraction coupling in gastrointestinal and other smooth muscles. Annu Rev Physiol 61: 85-115, 1999.
15. Bouton C, and Demple B. Nitric oxide-inducible expression of heme oxygenase-1 in human cells. Translation-dependent stabilization of the mRNA and evidence for direct action of nitric oxide. J Biol Chem 275: 32688-32693, 2000.
16. Bradley KK, Buxton IL, Barber JE, McGaw T, and Bradley ME. Nitric oxide relaxes human myometrium by a cGMP-independent mechanism. Am J Physiol 275: C1668-C1673, 1998.
17. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31: 577-596, 1999.
18. Brenman JE, and Bredt DS. Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7: 374-378, 1997.
19. Chandra A, Srivastava S, Petrash JM, Bhatnagar A, and Srivastava SK. Modification of aldose reductase by S-nitrosoglutathione. Biochemistry 36: 15801-15809, 1997.
20. Ciorba MA, Heinemann SH, Weissbach H, Brot N, and Hoshi T. Modulation of potassium channel function by methionine oxidation and reduction. Proc Natl Acad Sci U S A 94: 9932-9937, 1997.
21. + channels by methionine oxidation: effect of nitric oxide and vitamin C. FEBS Lett 442: 48-52, 1999.
22. Colasanti M, Persichini T, Venturini G, and Ascenzi P. S-Nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. UBMB Life 48: 25-31, 1999.
23. Collison MW, and Thomas JA. S-Thiolation of cytoplasmic cardiac creatine kinase in heart cells treated with diamide. Biochim Biophys Acta 928: 121-129, 1987.
24. Day YJ, Gao Z, Tan PC, and Linden J. ATP sensitive potassium channel and myocardial preconditioning. Acta Anaesthesiol Sin 37: 121-131, 1999.
25. D'Emilia DM, and Lipton SA. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures. Neurosci Lett 265: 103-106, 1999.
26. Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul 36: 151-180, 2000.
27. Dow LK, Changela A, Hefner HE, and Churchill ME. Oxidation of a critical methionine modulates DNA binding of the Drosophila melanogaster high mobility group protein, HMG-D. FEBS Lett 414: 514-520, 1997.
28. Drapier JC, and Hibbs JB Jr. Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Methods Enzymol 269: 26-36, 1996.
29. Dugas B, Debre P, and Moncada S. Nitric oxide, a vital poison inside the immune and inflammatory network. Res Immunol 146: 664-670, 1995.
30. Espey MG, Miranda KM, Feelisch M, Fukuto J, Grisham MB, Vitek MP, and Wink DA. Mechanisms of cell death governed by the balance between nitrosative and oxidative stress. Ann N Y Acad Sci 899: 209-221, 2000.
31. Eu JP, Liu L, Zeng M, and Stamler JS. An apoptotic model for nitrosative stress. Biochemistry 39: 1040-1047, 2000.
32. 2 sensor and NO signaling functions. Cell 102: 499-509, 2000.
33. Fleming I, and Busse R. Signal transduction of eNOS activation. Cardiovasc Res 43: 532-541, 1999.
34. Furchgott RF, and Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
35. Garbers DL, and Dubois SK. The molecular basis of hypertension. Annu Rev Biochem 68: 127-155, 1999.
36. Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, and Schechter AN. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A 97: 9943-9948, 2000.
37. Glockzin S, von Knethen A, Scheffner M, and Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 274: 19581-19586, 1999.
38. Gosgnach W, Messika-Zeitoun D, Gonzalez W, Philipe M, and Michel JB. Shear stress induces iNOS expression in cultured smooth muscle cells: role of oxidative stress. Am J Physiol Cell Physiol 279: C1880-C1888, 2000.
39. 2 and peroxynitrite in mem-branes: physiological implications. Free Radic Res 31: 597-606, 1999.
40. Gow AJ, Benjamin P, Luchsinger JR, Pawloski DJ, and Stamler JS The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 96: 9027-9032, 1999.
41. Gryglewski RJ, Palmer RM, and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456, 1986.
42. Gutteridge JM, and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899: 136-147, 2000.
43. Hansson T, Nordlund P, and Aqvist J. Energetics of nucleophile activation in a protein tyrosine phosphatase. J Mol Biol 265: 118-127, 1997.
44. Hart JD, and Dulhunty AF. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J Membr Biol 173: 227-236, 2000.
45. Heck DE. Molecular mechanisms regulating nitric oxide biosynthesis: role of xenobiotics in epithelial inflammation. Adv Exp Med Biol 387: 171-176, 1996.
46. Heck DE, Bisaccia E, Armus S, and Laskin JD. Production of hydrogen peroxide by cutaneous T-cell lymphoma following photopheresis with psoralens and ultraviolet light. Cancer Chemother Pharmacol 28: 344-350, 1991.
47. Hemmens B, and Mayer B. Enzymology of nitric oxide synthases. Methods Mol Biol 100: 1-32, 1998.
48. Hibbs JB Jr. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res Immunol 142: 565-569, 1991.
49. 2+-dependent stimulation of L-arginine transport in human platelets. Thromb Res 91: 113-120, 1998.
50. Huang KP, Huang FL, Li J, Schuck P, and McPhie P. Calcium-sensitive interaction between calmodulin and modified forms of rat brain neurogranin/RC3. Biochemistry 39: 7291-7299, 2000.
51. Ignarro LJ. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol 67: 1-7, 1990.
52. Ignarro LJ, Cirino G, Casini A, and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34: 879-886, 1999.
53. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356: 1-11, 1998.
54. Ishida A, Sasaguri T, Miwa Y, Kosaka C, Taba Y, and Abumiya T. Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/ Cip1/Sdi1) in vascular smooth muscle cells. Mol Pharmacol 56: 938-946, 1999.
55. Iwai K, Drake SK, Wehr NB, Weissman AM, LaVaute T, Minato N, Klausner RD, Levine RL, and Rouault TA. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A 95: 4924-1928, 1998.
56. Jakob U, Muse W, Eser M, and Bardwell JC. Chaperone activity with a redox switch. Cell 96: 341-352, 1999.
57. 2+. Am J Physiol Lung Cell Mol Physiol 278: L899-L905, 2000.
58. Janssen YM, Matalon S, and Mossman BT. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol 273: L789-L796, 1997.
59. Ji Y, Akerboom TP, Sies H, and Thomas JA. S-Nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitrosoglutathione. Arch Biochem Biophys 362: 67-78, 1999.
60. Jourd'heuil D, Hallen K, Feelisch M, and Grisham MB. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med 28: 409-417, 2000.
61. Kang JG, Paget MS, Seok YJ, Hahn MY, Bae JB, Hahn JS, Kleanthous C, Buttner MJ, and Roe JH. RsrA, an anti-sigma factor regulated by redox change. EMBO J 18: 4292-4298, 1999.
62. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, Settle SL, Currie MG, and Nickols GA. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci U S A 91: 3569-3573, 1994.
63. Kaye DM, Wiviott SD, Kobzik L, Kelly RA, and Smith TW. S-Nitrosothiols inhibit neuronal norepinephrine transport. Am J Physiol 272: H875-H883, 1997.
64. Kaye DM, Gruskin S, Smith AI, and Esler MD. Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation. Br J Pharmacol 130: 1060-1064, 2000.
65. Keefer LK, and Wink DA. DNA damage and nitric oxide. Adv Exp Med Biol 387: 177-185, 1996.
66. Keshive M, Singh S, Wishnok JS, Tannenbaum SR, and Deen WM. Kinetics of S-nitrosation of thiols in nitric oxide solutions. Chem Res Toxicol 9: 988-993, 1996.
67. Kibbe M, Billiar T, and Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 43: 650-657, 1999.
68. Kibbe MR, Li J, Nie S, Watkins SC, Lizonova A, Kovesdi I, Simmons RL, Billiar TR, and Tzeng E. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31: 1214-1228, 2000.
69. Kim WK. S-Nitrosation ameliorates homocysteine-induced neurotoxicity and calcium responses in primary culture of rat cortical neurons. Neurosci Lett 265: 99-102, 1999.
70. -. Neuron 24: 461-469, 1999.
71. Kim YM, Talanian RV, Li J, and Billiar TR. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J Immunol 161: 4122-4128, 1998.
72. Kiroycheva M, Ahmed F, Anthony GM, Szabo C, Southan GJ, and Bank N. Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol 11: 1026-1032, 2000.
73. Klatt P, and Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 267: 4928-4944, 2000.
74. Klatt P, Pineda MDE, Molina EP, Perez-Sala D, and Lamas S. Novel application of S-nitrosoglutathione-Sepharose to identify proteins that are potential targets for S-nitrosoglutathione-induced mixed-disulphide formation. Biochem J 349: 567-578, 2000.
75. Koh TJ, and Tidball JG. Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. Am J Physiol Cell Physiol 279: C806-C812, 2000.
76. Koppenol WH. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 25: 385-391, 1998.
77. Koppenol WH. Chemistry of peroxynitrite and its relevance to biological systems. Met Ions Biol Syst 36: 597-619, 1999.
78. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, and Beckman JS. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5: 834-842, 1992.
79. Kroncke KD, Fehsel K, and Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1: 107-120, 1997.
80. + (BKCa) channels in myocytes of the guinea-pig taenia caeci. J Physiol (Lond) 525: 363-376, 2000.
81. Laskin DL, and Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 35: 655-677, 1995.
82. Laskin DL, Heck DE, and Laskin JD. Role of inflammatory cytokines and nitric oxide in hepatic and pulmonary toxicity. Toxicol Lett 102-103: 289-293, 1998.
83. Levin RM, Hypolite JA, and Broderick GA. Evidence for a role of intracellular-calcium release in nitric oxide-stimulated relaxation of the rabbit corpus cavernosum. J Androl 18: 246-249, 1997.
84. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997.
85. Liaudet L, Soriano FG, and Szabo C. Biology of nitric oxide signaling. Crit Care Med 28: N37-N52, 2000.
86. Linz W, Wohlfart P, Scholkens BA, Malinski T, and Wiemer G. Interactions among ACE, kinins and NO. Cardiovasc Res 43: 549-561, 1999.
87. Lou MF. Thiol regulation in the lens. J Ocul Pharmacol Ther 16: 137-148, 2000.
88. Lowik CW, Nibbering PH, van de Ruit M, and Papapoulos SE. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93: 1465-1472, 1994.
89. Marshall HE, Merchant K, and Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J 14: 1889-1900, 2000.
90. Mayer B, and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22: 477-481, 1997.
91. Minor RL, Myers PR, Guerra R, Bates JN, and Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86: 2109-2116, 1990.
92. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 811: 60-67, 1997.
93. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
94. Nathan C, and Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97: 8841-8848, 2000.
95. Nathan CF, and Stuehr DJ. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70, 1991.
96. +ATP channels in nitric oxide-induced inhibition of spontaneous contractile activity of the nonpregnant human myometrium. Biochem Biophys Res Commun 253: 653-657, 1998.
97. O'Donnell VB, Eiserich JP, Bloodsworth A, Chumley PH, Kirk M, Barnes S, Darley-Usmar VM, and Freeman BA. Nitration of unsaturated fatty acids by nitric oxide-derived reactive species. Methods Enzymol 301: 454-470, 1999.
98. Ortega A, and Artinano A. Nitric oxide reactivity and mechanisms involved in its biological effects. Pharmacol Res 42: 421-427, 2000.
99. Ortega A, Puerro M, Lopez-Miranda V, and Aleixandre A. The role of endothelium in the calcium-induced reduction of the contractile response of the rabbit aorta. Gen Pharmacol 28: 745-752, 1997.
100. Padgett CM, and Whorton AR. Cellular responses to nitric oxide: role of protein S-thiolation/dethiolation. Arch Biochem Biophys 358: 232-242, 1998.
101. Paget MS, Kang JG, Roe JH, and Buttner MJ. sigmaR, an RNA polymerase sigma factor that modulates expression of the thioredoxin system in response to oxidative stress in Streptomyces coelicolor A3(2). EMBO J 17: 5776-5782, 1998.
102. Panasenko OM, Sharov VS, Briviba K, and Sies H. Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch Biochem Biophys 373: 302-305, 2000.
103. Park JW. Reaction of S-nitrosoglutathione with sulfhydryl groups in protein. Biochem Biophys Res Commun 152: 916-920, 1988.
104. Patel RP. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic Biol Med 28: 1518-1525, 2000.
105. Payen D, Bernard C, and Beloucif S. Nitric oxide in sepsis. Clin Chest Med 17: 333-350, 1996.
106. Pearce LL, Wasserloos K, St Croix CM, Gandley R, Levitan ES, and Pitt BR. Metallothionein, nitric oxide and zinc homeostasis in vascular endothelial cells. J Nutr 130: 1467S-1470S, 2000.
107. Percival MD, Ouellet M, Campagnolo C, Claveau D, and Li C. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 38: 13574-13583, 1999.
108. Sandirasegarane L, Charles R, Bourbon N, and Kester M. NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: implications for vascular growth arrest. Am J Physiol Cell Physiol 279: C225-C235, 2000.
109. Sastry PS, and Rao KS. Apoptosis and the nervous system. J Neurochem 74: 1-20, 2000.
110. Simon DI, Mullins ME, Jia L, Gaston B, Singel DJ, and Stamler JS. Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A 93: 4736-4741, 1996.
111. Singh SP, Wishnok JS, Keshive M, Deen WM, and Tannenbaum SR. The chemistry of the S-nitrosoglutathione/glutathione system. Proc Natl Acad Sci U S A 93: 14428-14433, 1996.
112. Sloane JA, Hollander W, Moss MB, Rosene DL, and Abraham CR. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 20: 395-105, 1999.
113. Snyder SH, and Bredt DS. Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 12: 125-128, 1991.
114. Souza JM, Daikhin E, Yudkoff M, Raman CS, and Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 371: 169-178, 1999.
115. Squadrito GL, and Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 25: 392-403, 1998.
116. Squadrito GL, and Pryor WA. The nature of reactive species in systems that produce peroxynitrite. Chem Res Toxicol 11: 718-719, 1998.
117. Stamler JS. S-Nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 196: 19-36, 1995.
118. Stubauer G, Giuffre A, and Sarti P. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J Biol Chem 274: 28128-28133, 1999.
119. Tonks NK, and Neel BG. From form to function: signaling by protein tyrosine phosphatases. Cell 87: 365-368, 1996.
120. Upchurch GR, Welch GN, and Loscalzo J. The vascular biology of S-nitrosothiols, nitrosated derivatives of thiols. Vasc Med 1: 25-33, 1996.
121. Valdez LB, Alvarez S, Arnaiz SL, Schopfer F, Carreras MC, Poderoso JJ, and Boveris A. Reactions of peroxynitrite in the mitochondrial matrix. Free Radic Biol Med 29: 349-356, 2000.
122. Vargiu C, Belliardo S, Cravanzola C, Grillo MA, and Colombatto S. Oxygen regulation of rat hepatocyte iNOS gene expression. J Hepatol 32: 567-573, 2000.
123. Venturini G, Salvati L, Muolo M, Colasanti M, Gradoni L, and Ascenzi P. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi. Biochem Biophys Res Commun 270: 437-441, 2000.
124. Venturini G, Colasanti M, Salvati L, Gradoni L, and Ascenzi P. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease. Biochem Biophys Res Commun 267: 190-193, 2000.
125. Verbeuren TJ, Jordaens FH, Van Hove CE, Van Hoydonck AE, and Herman AG. Release and vascular activity of endothelium-derived relaxing factor in atherosclerotic rabbit aorta. Eur J Pharmacol 191: 173-184, 1990.
126. Viner RI, Williams TD, and Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38: 12408-12415, 1999.
127. Viner RI, Ferrington DA, Huhmer AF, Bigelow DJ, and Schoneich C. Accumulation of nitrotyrosine on the SERCA2a isoform of SR Ca-ATPase of rat skeletal muscle during aging: a peroxynitrite-mediated process? FEBS Lett 379: 286-290, 1996.
128. Violi F, Marino R, Milite MT, and Loffredo L. Nitric oxide and its role in lipid peroxidation. Diabetes Metab Res Rev 15: 283-288, 1999.
129. 2+ entry in mouse parotid acini. Am J Physiol 277: C262-C270, 1999.
130. White CR, Darley-Usmar V, McAdams M, Berrington WR, Gore J, Thompson JA, Parks DA, Tarpey MM, and Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93: 8745-8749, 1996.
131. Wink DA, and Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25: 434-456, 1998.
132. Wink DA, Miranda KM, and Espey MG. Effects of oxidative and nitrosative stress in cytotoxicity. Semin Perinatol 24: 20-23, 2000.
133. Wolin MS. Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 3: 1-17, 1996.
134. Woznichak MM, Overcast JD, Robertson K, Neumann HM, and May SW. Reaction of phenyl-aminoethyl selenides with peroxynitrite and hydrogen peroxide. Arch Biochem Biophys 379: 314-320, 2000.
135. Xian M, Chen X, Liu Z, Wang K, and Wang PG. Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides. J Biol Chem 275: 20467-20473, 2000.
136. Xu KY, Huso DL, Dawson TM, Bredt DS, and Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96: 657-662, 1999.
137. Xu L, Eu JP, Meissner G, and Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-237, 1998.
138. 2+ mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 279: H873-H881, 2000.
139. Zheng M, Aslund F, and Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279: 1718-1721, 1998.